Clinical Trial Update: A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This entry notes a Phase I/II clinical trial evaluating AST-3424 in subjects with advanced solid tumors and hepatocellular carcinoma, with the study currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• AST-3424 (AST-3424)

Snippet

Sponsor: Ascentawits Pharmaceuticals, Ltd | Conditions: Advanced Solid Tumors, Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING